Evaluation of 99mTc-Labeled Bevacizumab–N-HYNIC Conjugate in Human Ovarian Tumor Xenografts-Reference-Cited by-同舟云学术

Evaluation of 99mTc-Labeled Bevacizumab–N-HYNIC Conjugate in Human Ovarian Tumor Xenografts

Published:2018-04 Issue:3 Volume:33 Page:96-102
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Shah Syed Qaiser¹,Mahmood Samia¹

Affiliation:

1. Biochemistry Section, Institute of Chemical Sciences, University of Peshawar, Peshawar, K.P.K., Pakistan.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2017.2323

Reference30 articles.

1. Angiogenesis Inhibitors: Current Strategies and Future Prospects

2. Ovarian tissue culture in the presence of VEGF and fetuin stimulates follicle growth and steroidogenesis

3. VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors

4. Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein

5. Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 99mTc-p-SCN-Bzl-TCMC-bevacizumab for vascular endothelial growth factor (VEGF) receptor imaging using ovarian cancer model;Journal of Radioanalytical and Nuclear Chemistry;2020-05-14

2. Synthesis and preclinical investigation of 99mTc-p-SCN-Bzl-DTPA-cetuximab for targeting EGFR using head and neck squamous cell carcinoma (HNSCC) xenografts;Molecular Biology Reports;2019-01-24